These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19182996)

  • 1. Generation of recombinant vaccinia viruses via green fluorescent protein selection.
    Popov S; Mirshahidi S; Essono S; Song R; Wang X; Ruprecht RM
    DNA Cell Biol; 2009 Mar; 28(3):103-8. PubMed ID: 19182996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
    McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
    Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of herpes simplex virus thymidine kinase, mediated by vaccinia virus early promoters.
    Sharif A; Mars M; Dru A; Beaud G
    Res Virol; 1989; 140(2):103-13. PubMed ID: 2547234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and evaluation of a new triple-gene expression cassette vaccinia virus shuttle vector.
    Du S; Li C; Wang Y; Liu C; Ren D; Li Y; Qin Y; Wang M; Sun D; Zhu N; Jin N
    J Virol Methods; 2012 Nov; 185(2):175-83. PubMed ID: 22766182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.
    Byrd CM; Hruby DE
    Methods Mol Biol; 2004; 269():31-40. PubMed ID: 15114005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems encountered in bicistronic IRES-GFP expression vectors employed in functional analyses of GC-induced genes.
    Mansha M; Wasim M; Ploner C; Hussain A; Latif AA; Tariq M; Kofler A
    Mol Biol Rep; 2012 Dec; 39(12):10227-34. PubMed ID: 23076521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of the LIVP-GFP recombinant vaccinia virus.
    Petrov IS; Goncharova EP; Kolosova IV; Pozdnyakov SG; Shchelkunov SN; Zenkova MA; Vlasov VV
    Dokl Biol Sci; 2013; 451():248-52. PubMed ID: 23975469
    [No Abstract]   [Full Text] [Related]  

  • 8. An efficient method for generating poxvirus recombinants in the absence of selection.
    Rice AD; Gray SA; Li Y; Damon I; Moyer RW
    Viruses; 2011 Mar; 3(3):217-32. PubMed ID: 21494427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bi-Reporter Vaccinia Virus for Tracking Viral Infections
    Chiem K; Lorenzo MM; Rangel-Moreno J; Garcia-Hernandez ML; Park JG; Nogales A; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2021 Dec; 9(3):e0160121. PubMed ID: 34817228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia as a vector for tumor-directed gene therapy: biodistribution of a thymidine kinase-deleted mutant.
    Puhlmann M; Brown CK; Gnant M; Huang J; Libutti SK; Alexander HR; Bartlett DL
    Cancer Gene Ther; 2000 Jan; 7(1):66-73. PubMed ID: 10678358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus.
    Morrison HG; Goldsmith CS; Regnery HL; Auperin DD
    Virus Res; 1991 Mar; 18(2-3):231-41. PubMed ID: 2042398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase.
    Wilson EM; Franke CA; Black ME; Hruby DE
    Gene; 1989 Apr; 77(1):69-78. PubMed ID: 2744489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
    Taylor G; Stott EJ; Wertz G; Ball A
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():125-30. PubMed ID: 1990060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR-based method for the introduction of mutations in genes cloned and expressed in vaccinia virus.
    Lorenzo MM; Blasco R
    Biotechniques; 1998 Feb; 24(2):308-13. PubMed ID: 9494734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the ATP-binding domain of vaccinia virus thymidine kinase.
    Black ME; Hruby DE
    J Biol Chem; 1990 Oct; 265(29):17584-92. PubMed ID: 2211649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors.
    Broder CC; Kennedy PE; Michaels F; Berger EA
    Gene; 1994 May; 142(2):167-74. PubMed ID: 8194748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GFP-based screen for growth-arrested, recombinant protein-producing cells.
    Yuk IH; Wildt S; Jolicoeur M; Wang DI; Stephanopoulos G
    Biotechnol Bioeng; 2002 Jul; 79(1):74-82. PubMed ID: 17590933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.
    Garg H; Joshi A
    Hum Gene Ther; 2016 May; 27(5):400-15. PubMed ID: 26800572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A macrophage fusion assay for rapid screening of cloned HIV-1 Env using dual recombinant vaccinia viruses expressing distinct RNA polymerases.
    Isaacs SN; Yi Y; Singh A; Collman RG
    J Virol Methods; 1999 Aug; 81(1-2):55-61. PubMed ID: 10488761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rana grylio virus as a vector for foreign gene expression in fish cells.
    He LB; Ke F; Zhang QY
    Virus Res; 2012 Jan; 163(1):66-73. PubMed ID: 21889962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.